Abstract
Glutamate racemase is an enzyme essential to the bacterial cell wall biosynthesis pathway, and has therefore been considered as a target for antibacterial drug discovery. We characterized the glutamate racemases of several pathogenic bacteria using structural and biochemical approaches. Here we describe three distinct mechanisms of regulation for the family of glutamate racemases: allosteric activation by metabolic precursors, kinetic regulation through substrate inhibition, and d-glutamate recycling using a d-amino acid transaminase. In a search for selective inhibitors, we identified a series of uncompetitive inhibitors specifically targeting Helicobacter pylori glutamate racemase that bind to a cryptic allosteric site, and used these inhibitors to probe the mechanistic and dynamic features of the enzyme. These structural, kinetic and mutational studies provide insight into the physiological regulation of these essential enzymes and provide a basis for designing narrow-spectrum antimicrobial agents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van Heijenoort, J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat. Prod. Rep. 18, 503–519 (2001)
Tanner, M. E. & Miao, S. The synthesis and stability of aziridino-glutamate, an irreversible inhibitor of glutamate racemase. Tetrahedr. Lett. 35, 4073–4076 (1994)
Ashiuchi, M., Yoshimura, T., Esaki, N., Ueno, H. & Soda, K. Inactivation of glutamate racemase of Pediococcus pentosaceus with l-serine O-sulfate. Biosci. Biotechnol. Biochem. 57, 1978–1979 (1993)
de Dios, A. et al. 4-Substituted d-glutamic acid analogues: The first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity. J. Med. Chem. 45, 4559–4570 (2002)
Glavas, S. & Tanner, M. E. The inhibition of glutamate racemase by d-N-hydroxyglutamate. Bioorg. Med. Chem. Lett. 7, 2265–2270 (1997)
Newsholme, P., Procopio, J., Lima, M. M. R., Pithon-Curi, T. C. & Curi, R. Glutamine and glutamate—their central role in cell metabolism and function. Cell Biochem. Funct. 21, 1–9 (2003)
Doublet, P., van Heijenoort, J. & Mengin-Lecreulx, D. The glutamate racemase activity from Escherichia coli is regulated by peptidoglycan precursor UDP-N-acetylmuramoyl-l-alanine. Biochemistry 33, 5285–5290 (1994)
Ho, H.-T. et al. UDP-N-acetylmuramyl-l-alanine functions as an activator in the regulation of the Escherichia coli glutamate racemase activity. Biochemistry 34, 2464–2470 (1995)
Doublet, P., van Heijenoort, J. & Mengin-Lecreulx, D. Regulation of the glutamate racemase of Escherichia coli investigated by site-directed mutagenesis. Microb. Drug Resist. Mechanisms Epidemiol. Dis. 2, 43–49 (1996)
Fisher, L. M., Albery, W. J. & Knowles, J. R. Energetics of proline racemase: racemization of unlabeled proline in the unsaturated, saturated, and oversaturated regimes. Biochemistry 25, 2529–2537 (1986)
Mengin-Lecreulx, D., Flouret, B. & van Heijenoort, J. Cytoplasmic steps of peptidoglycan synthesis in Escherichia coli. J. Bacteriol. 151, 1109–1117 (1982)
Fotheringham, I. G., Bledig, S. A. & Taylor, P. P. Characterization of the genes encoding d-amino acid transaminase and glutamate racemase, two d-glutamate biosynthetic enzymes of Bacillus sphaericus ATCC 10208. J. Bacteriol. 180, 4319–4323 (1998)
Pucci, M. J., Thanassi, J. A., Ho, H. T., Falk, P. J. & Dougherty, T. J. Staphylococcus haemolyticus contains two d-glutamic acid biosynthetic activities, a glutamate racemase and a d-amino acid transaminase. J. Bacteriol. 177, 336–342 (1995)
Song, J. H. et al. Identification of essential genes in Streptococcus pneumoniae by allelic replacement mutagenesis. Mol. Cells 19, 365–374 (2005)
Wang, L. & Zamudio, C. A method for predicting operons in prokaryotes. US patent number US2005/0026189A1. (2005)
Ruzheinikov, S. N. et al. Substrate-induced conformational changes in Bacillus subtilis glutamate racemase and their implications for drug discovery. Structure 13, 1707–1713 (2005)
Glavas, S. & Tanner, M. E. Active site residues of glutamate racemase. Biochemistry 40, 6199–6204 (2001)
Hwang, K. Y. et al. Structure and mechanism of glutamate racemase from Aquifex pyrophilus. Nature Struct. Biol. 6, 422–426 (1999)
McGovern, S. L., Helfand, B. T., Feng, B. & Shoichet, B. K. A specific mechanism of nonspecific inhibition. J. Med. Chem. 46, 4265–4272 (2003)
Seidler, J., McGovern, S. L., Doman, T. N. & Shoichet, B. K. Identification and prediction of promiscuous aggregating inhibitors among known drugs. J. Med. Chem. 46, 4477–4486 (2003)
Ghosh, N. K. & Fishman, W. H. On the mechanism of inhibition of intestinal alkaline phosphatase by l-phenylalanine. J. Biol. Chem. 241, 2516–2522 (1966)
Hardy, J. A. & Wells, J. A. Searching for new allosteric sites in enzymes. Curr. Opin. Struct. Biol. 14, 706–715 (2004)
Wiesmann, C. et al. Allosteric inhibition of protein tyrosine phosphatase 1B. Nature Struct. Mol. Biol. 11, 730–737 (2004)
Pargellis, C. et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature Struct. Biol. 9, 268–272 (2002)
Oikonomakos, N. G., Skamnaki, V. T., Tsitsanou, K. E., Gavalas, N. G. & Johnson, L. N. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Struct. Fold. Des. 8, 575–584 (2000)
Hardy, J. A., Lam, J., Nguyen, J. T., O'Brien, T. & Wells, J. A. Discovery of an allosteric site in the caspases. Proc. Natl Acad. Sci. USA 101, 12461–12466 (2004)
Anderson, M. et al. Crystals of MurI from Gram negative, Gram positive, and atypical bacterium; computer-assisted method for screening, identifying, and designing inhibitors of MurI; inhibitors of MurI; and uses thereof. US patent number US2005/0037478 A1. (2005)
Acknowledgements
We thank M. Gowravaram for compound synthesis and characterization, and all members of the MurI Team and collaborators across AstraZeneca for support of this work. The atomic coordinates of the protein structures have been deposited in the European Bioinformatics Institute Macromolecular Structure Database: H. pylori MurI complexed with D-glutamate (Native I, accession code 2jfx; Native II, accession code 2jfy); H. pylori complex with D-glutamate and compound A, accession code 2jfz; E. coli MurI complexed with L-glutamate and UDP-MurNAc-Ala, accession code 2jfn; S. aureus MurI complexed with D-glutamate, accession code 2jfq; E. faecalis MurI complexed with D- or L-glutamate, accession code 2jfo; E. faecalis MurI complexed with D-glutamate, accession code 2jfp; E. faecium MurI complexed with phosphate, accession code 2jfu; E. faecium MurI complexed with citrate, accession code 2jfv; E. faecium MurI complexed with tartrate, accession code 2jfw.
Author Contributions S.L.F and T.L. contributed equally to this work. S.L.F., G.K., D.T.N. and T.A.K. performed the protein biochemical and kinetic characterizations, Y.X. solved the H. pylori MurI Native I structure and T.L. solved all other protein structures. R.H.A.F. performed the NMR studies, R.A.A. performed the phylogenetic, genomic and sequence analyses and B.L.M.dJ. performed the microbial physiology analyses. All authors discussed the results, contributed and commented on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The atomic coordinates of the protein structures have been deposited in the European Bioinformatics Institute Macromolecular Structure Database: H. pylori MurI complexed with d-glutamate (Native I, accession code 2jfx; Native II, accession code 2jfy); H. pylori complex with d-glutamate and compound A, accession code 2jfz; E. coli MurI complexed with l-glutamate and UDP-MurNAc-Ala, accession code 2jfn; S. aureus MurI complexed with d-glutamate, accession code 2jfq; E. faecalis MurI complexed with d- or l-glutamate, accession code 2jfo; E. faecalis MurI complexed with d-glutamate, accession code 2jfp; E. faecium MurI complexed with phosphate, accession code 2jfu; E. faecium MurI complexed with citrate, accession code 2jfv; E. faecium MurI complexed with tartrate, accession code 2jfw. Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Supplementary information
Supplementary Information 1
This file contains Supplementary Methods, Supplementary Tables S1-S9, Supplementary Figures S1-S14 with Legends. (PDF 4935 kb)
Rights and permissions
About this article
Cite this article
Lundqvist, T., Fisher, S., Kern, G. et al. Exploitation of structural and regulatory diversity in glutamate racemases. Nature 447, 817–822 (2007). https://doi.org/10.1038/nature05689
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature05689
This article is cited by
-
Targeting multi-drug-resistant Acinetobacter baumannii: a structure-based approach to identify the promising lead candidates against glutamate racemase
Journal of Molecular Modeling (2023)
-
Decrypting a cryptic allosteric pocket in H. pylori glutamate racemase
Communications Chemistry (2021)
-
Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids
Scientific Reports (2020)
-
Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis—an enzyme involved in peptidoglycan biosynthesis
Applied Microbiology and Biotechnology (2019)
-
Sulfamic acid-catalyzed, environmentally benign synthesis of bis-tetronic acids at ambient temperature
Research on Chemical Intermediates (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.